0
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Combination therapy or monotherapy for the depressed type of schizoaffective disorder

, &
Pages 91-101 | Published online: 09 Feb 2009

References

  • LebrunTWilmotteJSchizoaffective disorder: its nosographic significanceActa Psychiatr Belg1993932202358036940
  • LakeCRHurwitzNSchizoaffective disorders are psychotic mood disorders; there are no schizoaffective disordersPsych Res2006143255287
  • Vollmer-LarsenAJacobsenTBHemmingsenRParnasJSchizoaffective disorder – the reliability of its clinical diagnostic useActa Psychiatr Scand200611340240716603031
  • KolibášEČaplováTFleischerJŠpeciálna psychiatriaBratislavaVydavatel’stvo UK199665
  • EbertMHLoosenPTNurcombeBCurrent Diagnosis and Treatment in PsychiatryUSALange Medical Books/McGraw Hill2000
  • LipkovichIDeberdtWBuckleyPFPrediction of combined symptomatic and functional outcome in patients with schizophrenia and schizoaffective disorderNeurotherapeutics20063410
  • SirisSGDepression in schizophrenia: perspective in the area of “Atypical” antipsychotic agentsAm J Psychiatry20001571379138910964850
  • KarowASchnedlerDNaberDWhat would the patient choose? Subjective comparison of atypical and typical neurolepticsPharma-copsychiatry2006394751
  • ClarkREBartelsSJMellmanTAPeacockWJRecent trends in antipsychotic combination therapy of schizophrenia and schizoaffective disorder: implications for state mental health policySchizophr Bull200228758412047024
  • TurnerMSStewartDWReview of the evidence for the long term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychosesJ Psychopharmacol200620203717046985
  • FlynnJGriegerTABenedekDMPharmacologic treatment of hospitalized patients with schizoaffective disorderPsych Serv2002539496
  • VojtekováL’HalarisAPospíšilRMonoterapia versus kombinovaná liečba akútnej fázy depresívneho typu schizoafektívnej poruchyPsych Pro Praxi200242529
  • DóciIKovářováMKovaničováMLiečba schizoafektívnej poruchy na Psychiatrickej klinike v Košiciach v roku 2002Psychiatrie20032Suppl2526
  • KaySRFiszbainAOplerLAThe Positive and Negative Syndrome Scale (PANSS) for schizophreniaSchizophr Bull1987132612763616518
  • AddingtonDAddingtonJSchisselBA depression rating scale for schizophrenicsSchizophr Res199032472512278986
  • AddingtonDAddingtonJMaticka-TyndaleEJoyceJReliability and validity of a depression rating scale for schizophrenicsSchizophr Res199262012081571313
  • GuyWECDEU Assessment for PsychopharmacologyRockvilleUS DHEW1976534537
  • HeinrichDWHanlonTECarpenterWTJrThe quality of life scale: an instrument for rating the schizophrenic deficit syndromeSchizophr Bull1984103883986474101
  • EndicottJSpitzerRLFleissJLCohenJThe global assessment scale: A procedure for measuring the overall severity of psychiatric disturbanceArch Gen Psychiatry197633767771
  • HoganTPAwadAGEastwoodRA self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validityPsychol Med1983131771836133297
  • RossCKStewardCASinacoreJMThe importance of patient preferences in the measurement of health care satisfactionMed Care199331113811498246642
  • SimpsonGMAngusJWSA rating scale for extrapyramidal side effectsActa Psychiatr Scand1970212Suppl1119
  • JanicakPGKeckPEDavisJMA double blind, randomized, prospective evaluation of the efficacy and safety of risperidone versus haloperidol in the treatment of schizoaffective disorderJ Clin Psycho-pharmacol200121360368
  • LeuchtSPitschel-WalzGAbrahamDKisslingWEfficacy and extra-pyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone and sertindole compared to conventional antipsychotics and placebo: a meta-analysis of randomized controlled trialsSchizophr Res19993551689988841
  • MarderSRMeibachRCRisperidone in the treatment of schizophreniaAm J Psychiatry19941518258357514366
  • HunterRHJoyCBKennedyEGilbodySMSongFRisperidone versus typical antipsychotic medication for schizophreniaCochrane Database Syst Rev20032CD00044012804396
  • Müller-SiechenederFMüllerMJHillertASzegediAWetzelHBenkertORisperidone versus haloperidol and amitriptyline in the treatment of patients with a combined psychotic and depressive syndromeJ Clin Psychopharmacol1998181111209555596
  • TempierRPawliukNInfluence of novel and conventional antipsychotic medication on subjective quality of lifeJ Psychiatr Neurosci200126131136
  • TiihonenJWahlbeckKLönnqvistJKlaukkaTIonnidisJPAVolavkaJHaukkaJEffectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up studyBMJ200633322422916825203

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.